1
Viral vectors are promising tools for the development of novel vaccines and vaccination approaches. Viral vector-based vaccines present advantages over traditional vaccines in that they can enhance a broad range of immunogenicity without an adjuvant and induce a robust cytotoxic T lymphocyte (CTL) response to eliminate virus-infected cells. During the last several decades, viral vectors have been extensively studied in animal models, and many types of viruses have been developed as vaccine vectors and entered clinical trials. The most promising method involves "prime-boost" strategies with other types of vaccines such as recombinant antigens or DNA vaccines. Viral vector is a promising system for the development of effective and safe vaccines for many important diseases. Creative Biolabs is professional in a wide range of vaccine technologies including Viral Vector Vaccine. Our scientists are confident in offering the best services and products upon request.